Healthcare >> CEO Interviews >> August 25, 2003
DR. IRENE HRUSOVSKY, President, Chief Executive Officer and a Director
at EraGen Biosciences, spearheads EraGen's work to drive genetic
diagnostics and drugs to market faster. She has empowered the company to
address compelling issues in genomic and proteomic research to meet the
needs of the current and future marketplace. Dr. Hrusovsky leads a team
comprised of industry experts who are well versed in the challenges of
commercializing breakthrough technologies for diagnostic and therapeutic
applications. Dr. Hrusovsky possesses nearly three decades of diverse
experience in healthcare business management and medical leadership. She
has extensive business experience in diagnostics and pharmaceuticals
with recognition for her excellent leadership and entrepreneurial
skills. Prior to joining EraGen, she served as Vice President, General
Medicine/Medical Marketing Strategy/Clinical Operations at
GlaxoSmithKline where she successfully designed and implemented new
business models for new product commercialization and for the company's
North American Clinical Operations. Prior to her position at Glaxo, Dr.
Hrusovsky spent over 20 years with Abbott Laboratories, where she held
various executive management positions in diagnostics, pharmaceuticals,
business development and new business ventures. Dr. Hrusovsky is a Board
Certified Pediatrician, educated in Canada, where she received her
Bachelor of Science degree in Biochemistry and Genetics at Vancouver and
her Doctor of Medicine degree at the University of British Columbia. Profile
Biosciences and then a picture of things as they are now at the company?
Dr. Hrusovsky: The company was founded in Florida in
